Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel dual mechanism of action reported for CP-248

May 29, 2002

CCI-779 well tolerated and active in renal cell carcinoma

May 28, 2002

CKD-602 evaluated clinically as a treatment for solid tumors

May 28, 2002

Novel epothilone examined for pharmacokinetic behavior in phase I trial

May 28, 2002

Clinical data for histone deacetylase inhibitor FR-901228 presented in Orlando

May 28, 2002

Safety of continuous infusions of GEM-231 and effects on serum extracellular PKA levels

May 28, 2002

CDK4 inhibitors with antitumor activity prepared and tested at Lilly

May 28, 2002

Acceptable toxicity, disease stabilization in patients treated with BMS-310705

May 27, 2002

MitoExtra NDA amendment accepted for filing

May 27, 2002

Camptothecin glycoconjugate well tolerated in early clinical trial in cancer patients

May 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...